Markets

ImmunoGen (IMGN) in Focus: Stock Rallies 14% - Tale of the Tape

ImmunoGen, Inc. ( IMGN ) was a big mover last session, as the company saw its shares surge nearly 14% on the day. This jump can be attributable to solid volume too with far more shares changing hands than in a normal session. This reverses the recent downtrend for the company as the stock is now down about 13.3% in the past one-month time frame.

In the last 7 days, this company did not witness any estimate revisions and the Zacks Consensus Estimate has remained unchanged over the same period. However, the recent price action is encouraging, so make sure to keep a close watch on this firm in the near future.

ImmunoGen currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Other better-ranked med-drug stocks include Cempra, Inc. ( CEMP ), Enanta Pharmaceuticals, Inc. ( ENTA ) and Lannett Company, Inc. ( LCI ), all carrying a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days . Click to get this free report >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

IMMUNOGEN INC (IMGN): Free Stock Analysis Report

LANNETT INC (LCI): Free Stock Analysis Report

ENANTA PHARMA (ENTA): Free Stock Analysis Report

CEMPRA INC (CEMP): Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

IMGN ENTA LCI

Other Topics

Investing Stocks

Latest Markets Videos